Skip to main content
GENINUS Inc. logo

GENINUS Inc. — Investor Relations & Filings

Ticker · 389030 ISIN · KR7389030008 KO Professional, scientific and technical activities
Open in API
Filings indexed 162 across all filing types
Latest filing 2026-06-09 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 389030

About GENINUS Inc.

https://www.kr-geninus.com/

GENINUS Inc. is a biotechnology company specializing in genomic and multi-omics analysis for precision medicine. The company provides comprehensive solutions for drug development, diagnostics, and clinical research, with a focus on single-cell analysis, cancer genome companion diagnostics, and AI-driven biomarker discovery. Its proprietary platforms include IntelliMed™ for clinical genomics, MEDINSIGHT™ for AI-powered digital pathology, and SPACEINSIGHT™, a cloud-based platform for spatial multi-omics data analysis. By integrating advanced analytics with artificial intelligence, GENINUS delivers genetic insights to support personalized treatment strategies, disease prevention, and the development of novel therapeutics.

Recent filings

Filing Released Lang Actions
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 85% confidence The document is a Korean stock exchange disclosure detailing the exercise of conversion rights for a convertible bond, showing the number of shares issued upon conversion, percentages, and listing date adjustments. This is an announcement of a capital change (issuance of new shares upon bond conversion), fitting the “Share Issue/Capital Change” category.
2026-06-09 Korean
[기재정정]전환청구권행사
Share Issue/Capital Change Classification · 90% confidence The document is a corporate disclosure in Korean detailing the exercise of convertible bond conversion rights, including the number of shares to be issued, conversion prices, and correction of listing dates. It represents an actual share issuance event (capital change) rather than a mere report notice or regulatory filing. This fits the “Share Issue/Capital Change” category (SHA).
2026-06-09 Korean
전환청구권행사
Share Issue/Capital Change Classification · 95% confidence The document is an announcement regarding the exercise of conversion rights under convertible bonds, detailing the number of shares to be issued, conversion price, and issuance schedule. This constitutes a share issue/capital change event. Therefore, it falls under the 'Share Issue/Capital Change' category.
2026-05-29 Korean
[기재정정]주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 85% confidence The document is a Korean large shareholding status report (“주식등의 대량보유상황보고서”), including a correction to an initial filing and detailed tables of shareholdings above threshold (7.38%). It is filed by an investor (KB Investment Co., Ltd.) notifying a major shareholding in the issuer. This matches the definition of a Major Shareholding Notification (MRQ).
2026-05-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 90% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” (report on insider or major shareholder holdings and changes), detailing ownership counts, percentages and transaction dates by an executive. This matches an insider dealing disclosure by a director/executive. Hence it is a Director’s Dealing report.
2026-05-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 95% confidence The document is a Korean “임원ㆍ주요주주 특정증권등 소유상황보고서” which details an officer’s holdings and changes in specific securities (conversion bonds, share counts before and after, acquisition/disposition). This is an insider shareholding disclosure by a director/executive, matching the definition of “Director's Dealing (Code: DIRS)”.
2026-05-29 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.